Fertility and Sterility
Volume 93, Issue 4 , Pages 1255-1259, 1 March 2010

Modulation of HOXA10 and other markers of endometrial receptivity by age and human chorionic gonadotropin in an endometrial explant model

  • Robin H. Fogle, M.D.

      Affiliations

    • Atlanta Center for Reproductive Medicine, Atlanta, Georgia
    • University of Southern California Keck School of Medicine, Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Los Angeles, California
    • Corresponding Author InformationReprint requests: Robin H. Fogle, M.D., Atlanta Center for Reproductive Medicine, 5909 Peachtree Dunwoody Road, Suite 720, Atlanta, Georgia 30328 (FAX: 770-592-2092).
  • ,
  • Aimin Li, M.D.

      Affiliations

    • University of Southern California Keck School of Medicine, Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Los Angeles, California
  • ,
  • Richard J. Paulson, M.D.

      Affiliations

    • University of Southern California Keck School of Medicine, Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Los Angeles, California

Received 24 May 2008; received in revised form 14 November 2008; accepted 14 November 2008. published online 07 January 2009.

Objective

To characterize the endometrial response to human chorionic gonadotropin (hCG), as influenced by uterine age, using endometrial receptivity markers including HOXA10, vascular endothelial growth factor (VEGF), and glycodelin in an endometrial explant culture system.

Design

In vitro molecular biology research.

Setting

Academic infertility clinic and molecular biology laboratory.

Patient(s)

Fourteen prospective recipients of egg donation (mean age, 44 ± 8 years).

Intervention(s)

Subjects received cyclical estrogen (E2) and progesterone (P4) and underwent an endometrial biopsy on day 7 of P4. Endometrial biopsy samples were cut into 1-mm3 pieces and cultured in Dulbecco's modified Eagle's medium/Ham's F-12 with E2 and P4, without (control) or with hCG (400, 4000, and 40,000 mIU/mL) on Millicell-CM inserts for 24 hours.

Main Outcome Measure(s)

Explant viability was assessed using immunohistochemistry (IHC). Semiquantitative polymerase chain reaction was performed to evaluate relative gene expression via mRNA levels of HOXA10, VEGF, and glycodelin.

Result(s)

Explant viability was confirmed on IHC by histology and Ki-67 staining, a marker of proliferation. HOXA10, VEGF, and glycodelin gene expression increased at all concentrations of hCG over those of controls. HOXA10 gene expression was inversely correlated with age (−0.08- ± 0.03-fold decrease in gene expression/year of age).

Conclusion(s)

The endometrial explant culture system is a promising model for the study of endometrial response as it maintains interactions among the stroma, glands, and epithelium. HOXA10, VEGF, and glycodelin all demonstrated increased gene expression in response to increasing hCG concentrations, supporting the role of hCG as a candidate protein for blastocyst-endometrial communication. Statistically significant associations between age and expression of HOXA10 provide novel evidence that uterine age may play a role in endometrial response on a molecular level.

Key Words: Endometrial receptivity, HOXA10, glycodelin, vascular endothelial growth factor, embryo implantation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 R.H.F. has nothing to disclose. A.L. has nothing to disclose. R.J.P. has nothing to disclose.

PII: S0015-0282(08)04547-0

doi:10.1016/j.fertnstert.2008.11.002

Fertility and Sterility
Volume 93, Issue 4 , Pages 1255-1259, 1 March 2010